By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Transgenomic, Inc. 

12325 Emmett Street

Omaha  Nebraska  68107  U.S.A.
Phone: 402-738-5480 Fax: 402-733-1932



Company News
Transgenomic, Inc. (TBIO) Highlights Unique Advantages Of Multiplexed ICE COLD-PCR At Personalized Medicine World Conference 1/26/2016 10:35:14 AM
Transgenomic, Inc. (TBIO) Launches New MX-ICP Panels For Liquid Biopsy Detection Of RAS And PIK3CA Tumor Mutations 1/19/2016 10:25:38 AM
Transgenomic, Inc. (TBIO) Announces Private Placement Financing 1/11/2016 2:17:55 PM
Transgenomic, Inc. (TBIO) Announces Conversion Of Series A and B Preferred Securities And Extension Of Loan Maturity Date 1/11/2016 2:16:50 PM
Transgenomic, Inc. (TBIO) Awarded NIH Grant To Augment Multiplexing Capabilities Of ICE COLD-PCR Technology In Collaboration With Dana-Farber Cancer Institute 12/23/2015 10:48:11 AM
Transgenomic, Inc. (TBIO) Reports U.S. Insurers Covering More Than 110 Million Lives Are Providing Reimbursement For Its Genomic Cancer Tests 12/9/2015 10:02:32 AM
Transgenomic, Inc. (TBIO) Finalizes Divestment Of Its Genetic Assays & Platforms Business Unit 12/1/2015 11:57:59 AM
Transgenomic, Inc. (TBIO) Reports Third Quarter 2015 Financial Results 11/13/2015 11:22:29 AM
Transgenomic, Inc. (TBIO) To Hold Third Quarter Financial Results Conference Call On November 12, 2015 At 5:00PM ET 11/12/2015 11:22:33 AM
Transgenomic, Inc. (TBIO) Launches Expanded MX-ICP Lung Cancer Analysis Panel For Liquid Biopsy Detection Of Key Actionable Tumor Mutations In Blood 11/5/2015 11:46:04 AM